- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/593 - 9,10-Secocholestane derivatives, e.g. cholecalciferol, vitamin D3
Patent holdings for IPC class A61K 31/593
Total number of patents in this class: 1205
10-year publication summary
102
|
140
|
117
|
131
|
136
|
129
|
140
|
178
|
145
|
34
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Wisconsin Alumni Research Foundation | 3774 |
48 |
EirGen Pharma Limited | 91 |
38 |
DSM IP Assets B.V. | 5856 |
37 |
Société des Produits Nestlé S.A. | 9672 |
32 |
LEO Pharma A/S | 455 |
18 |
Journey Medical Corporation | 93 |
13 |
N.V. Nutricia | 1022 |
13 |
Opko Ireland Global Holdings, Ltd. | 22 |
12 |
The Board of Trustees of the Leland Stanford Junior University | 6054 |
10 |
AMBO Innovations, LLC | 29 |
10 |
Nestec S.A. | 2777 |
9 |
Nutri Co., Ltd. | 49 |
9 |
Ldn Pharma Limited | 38 |
9 |
Opko Renal, LLC | 11 |
8 |
URGO Recherche Innovation et Developpement | 287 |
8 |
Nulixir Inc. | 37 |
8 |
The Trustees of the University of Pennsylvania | 4122 |
7 |
Daiichi Sankyo Company, Limited | 1829 |
6 |
Galderma S.A. | 174 |
6 |
Matthias W. Rath | 22 |
6 |
Other owners | 898 |